About Us
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors.
| Publication Type | Academic Article |
| Authors | Bajocchi G, Feldman S, Crystal R, Mastrangeli A |
| Journal | Nat Genet |
| Volume | 3 |
| Issue | 3 |
| Pagination | 229-34 |
| Date Published | 03/01/1993 |
| ISSN | 1061-4036 |
| Keywords | Adenoviruses, Human, Brain, Cerebral Ventricles, Ependyma, Genes, Bacterial, Transfection, alpha 1-Antitrypsin, beta-Galactosidase |
| Abstract | To evaluate the potential for adenovirus-mediated central nervous system (CNS) gene transfer, the replication deficient recombinant adenovirus vectors Ad.RSV beta gal (coding for beta-galactosidase) and Ad-alpha 1AT (coding for human alpha 1-antitrypsin) were administered to the lateral ventricle of rats. Ad.RSV beta gal transferred beta-galactosidase to ependymal cells lining the ventricles whereas Ad-alpha 1AT mediated alpha 1-antitrypsin secretion into the cerebral spinal fluid for 1 week. These observations, together with beta-galactosidase activity in the globus pallidus and substantia nigra following stereotactic administration of Ad.RSV beta gal to the globus pallidus, suggest that adenovirus vectors will be useful for CNS gene therapy. |
| DOI | 10.1038/ng0393-229 |
| PubMed ID | 8485578 |